Literature DB >> 28259055

Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas.

Jale Özyurt1, Hermann L Müller2, Monika Warmuth-Metz3, Christiane M Thiel4.   

Abstract

Patients with hypothalamic involvement of a sellar/parasellar tumor often suffer from cognitive and social-emotional deficits that a lesion in the hypothalamus cannot fully explain. It is conceivable that these deficits are partly due to distal changes in hypothalamic networks, evolving secondary to a focal lesion. Focusing on childhood-onset craniopharyngioma patients, we aimed at investigating the impact of hypothalamic lesions on gray and white matter areas densely connected to the hypothalamus, and to relate structural changes to neuropsychological deficits frequently observed in patients. We performed a voxel-based morphometric analysis based on data of 11 childhood-onset craniopharyngioma patients with hypothalamic tumor involvement, and 18 healthy controls (median age: 17.2 and 17.4 yrs.). Whole-brain analyses were used to test for volumetric differences between the groups (T-tests) and subsequent regression analyses were used to correlate neuropsychological performance with gray and white matter volumes within the patient group. Patients compared to controls had significantly reduced gray matter volumes in areas of the anterior and posterior limbic subsystems which are densely connected with the hypothalamus. In addition, a reduction in white matter volumes was observed in tracts connecting the hypothalamus to other limbic areas. Worse long-term memory retrieval was correlated with smaller gray matter volumes in the posterior cingulate cortex. Our data provide the first evidence that hypothalamic tumor involvement impacts gray and white matter volumes in limbic areas, outside the area of tumor growth. Notably, the functional range of the two limbic subsystems affected, strikingly parallels the two major domains of psychological complaints in patients i.e., deficits in episodic memory and in socio-emotional functioning. We suggest that focal hypothalamic lesions may trigger distal changes in connected brain areas, which then contribute to the impairments in cognitive, social and emotional performance often observable in patients, and not explicable by a hypothalamic lesion alone.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain tumors; Cognitive; Craniopharyngioma; Hypothalamus; Social-emotional

Mesh:

Year:  2017        PMID: 28259055     DOI: 10.1016/j.cortex.2017.01.017

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  5 in total

1.  Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma.

Authors:  Aylin Mehren; Jale Özyurt; Paula Zu Klampen; Svenja Boekhoff; Christiane M Thiel; Hermann L Müller
Journal:  J Neurooncol       Date:  2018-07-03       Impact factor: 4.130

2.  Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma.

Authors:  S Fjalldal; C Follin; D Svärd; L Rylander; S Gabery; Å Petersén; D van Westen; P C Sundgren; I M Björkman-Burtscher; J Lätt; B Ekman; A Johanson; E M Erfurth
Journal:  Eur J Endocrinol       Date:  2018-03-29       Impact factor: 6.664

3.  Social Cognition in Patients With Hypothalamic-Pituitary Tumors.

Authors:  Jale Özyurt; Aylin Mehren; Svenja Boekhoff; Hermann L Müller; Christiane M Thiel
Journal:  Front Oncol       Date:  2020-07-02       Impact factor: 6.244

Review 4.  Graph Theoretical Analysis of Brain Network Characteristics in Brain Tumor Patients: A Systematic Review.

Authors:  Eric S Semmel; Tobiloba R Quadri; Tricia Z King
Journal:  Neuropsychol Rev       Date:  2021-07-07       Impact factor: 6.940

5.  Cognitive interference processing in adults with childhood craniopharyngioma using functional magnetic resonance imaging.

Authors:  Daniel Svärd; Cecilia Follin; Sigridur Fjalldal; Robin Hellerstedt; Peter Mannfolk; Johan Mårtensson; Pia Sundgren; Eva Marie Erfurth
Journal:  Endocrine       Date:  2021-07-22       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.